Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells
Gao, Yuan, Pagnon, Joanne, Feng, Helen C., Konstantopoulos, Nicky, Jowett, Jeremy B. M. and Walder, Ken 2007, Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells, Biochemical and biophysical research communications, vol. 356, no. 3, pp. 636-641.
Attached Files
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name
Description
MIMEType
Size
Downloads
Title
Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells
SEPS1 (also called selenoprotein S, SelS, Tanis or VIMP) is a selenoprotein, localized predominantly in the ER membrane and also on the cell surface. In this report, we demonstrate that SEPS1 protein is also secreted from hepatoma cells but not from five other types of cells examined. The secretion can be abolished by the ER-Golgi transport inhibitor Brefeldin A and by the protein synthesis inhibitor cycloheximide. Using a sandwich ELISA, SEPS1 was detected in the sera of 65 out of 209 human subjects (31.1%, average = 15.7 ± 1.1 ng/mL). Fractionation of human serum indicated that SEPS1 was associated with LDL and possibly with VLDL. The function of plasma SEPS1 is unclear but may be related to lipoprotein metabolism.
Language
eng
Field of Research
110199 Medical Biochemistry and Metabolomics not elsewhere classified
Socio Economic Objective
970111 Expanding Knowledge in the Medical and Health Sciences